Britain's proposed assisted dying law for terminally ill people could be delayed until 2029, after the next election, casting ...

At present, Shingrix is used to prevent herpes zoster (shingles), a painful skin rash caused by the varicella-zoster virus.

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

The UK’s life sciences sector is missing out on £15bn annually due to declining global competitiveness, falling exports and ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...

The UK pharmaceutical intermediate market is on a steady growth trajectory, expected to reach USD 1,156.0 million in 2025 and expand to USD 1,553.2 million by 2035, reflecting a compound annual growth ...

The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs ...